EG384244 Activators
Foxl3, a member of the forkhead box family, stands as a pivotal DNA-binding transcription factor with a predicted role in RNA polymerase II-specific and cis-regulatory region sequence-specific DNA binding activities. This multifaceted gene is implicated in diverse cellular processes, including anatomical structure morphogenesis, cell differentiation, and the regulation of transcription by RNA polymerase II. Its importance is underscored by its potential influence on the intricate orchestration of genetic expression, steering cellular development and transcriptional regulation. The activation of Foxl3 is a complex process governed by a spectrum of regulatory mechanisms that delicately modulate its transcriptional activity. The intricacies involve the interplay of various cellular signaling pathways and the epigenetic landscape. For instance, histone modifications, such as acetylation, play a crucial role in Foxl3 activation, with certain chemicals influencing the enzymes responsible for these modifications. Additionally, the modulation of signaling pathways, including TGF-β, PI3K, and JNK, contributes to the nuanced activation of Foxl3. This diverse set of regulatory elements highlights the adaptability of Foxl3 in responding to different cellular cues, allowing it to fulfill its roles in transcriptional regulation and cell differentiation.
The general mechanisms of Foxl3 activation showcase its responsiveness to a range of chemical cues, emphasizing its role as a key regulator in cellular processes. The orchestrated interplay of these regulatory elements amplifies Foxl3's involvement in the intricate dance of genetic expression, steering cellular pathways toward anatomical structure morphogenesis and fostering cell differentiation. Unraveling the specific details of Foxl3 activation provides a deeper understanding of its functional significance in cellular physiology, shedding light on the intricate web of interactions that govern its transcriptional activity and cellular functions.
SEE ALSO...
Items 11 to 19 of 19 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which might affect the phosphorylation state of proteins that interact with or regulate CCDC35, leading to its functional inhibition. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
A RAF inhibitor that also inhibits several tyrosine kinases. Inhibition of these kinases could indirectly affect CCDC35 by altering the signaling pathways that regulate its activity or stabilization. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
An Aurora kinase inhibitor that disrupts chromosome alignment and segregation. By inhibiting Aurora kinases, it may indirectly inhibit CCDC35 if CCDC35 is involved in mitotic processes controlled by these kinases. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG up-regulates Foxl3 by modulating the Wnt pathway. It inhibits GSK-3β, preventing Foxl3 degradation, leading to increased transcriptional activity. Foxl3 then participates in the regulation of cell differentiation and transcription. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that leads to the inhibition of the AKT signaling pathway. This can result in the indirect inhibition of CCDC35 if it relies on PI3K/AKT pathway for its function or stability. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
BIX-01294 stimulates Foxl3 by inhibiting G9a histone methyltransferase. Inhibition of G9a promotes Foxl3 transcriptional activity, contributing to its involvement in transcriptional regulation and cell differentiation processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor that prevents the activation of the MAPK/ERK pathway, potentially leading to the indirect inhibition of CCDC35 through reduced phosphorylation of proteins that stabilize or activate CCDC35. | ||||||
Olomoucine | 101622-51-9 | sc-3509 sc-3509A | 5 mg 25 mg | $72.00 $274.00 | 12 | |
A cyclin-dependent kinase inhibitor that may inhibit cell cycle progression. By affecting these kinases, it could indirectly inhibit CCDC35 if its function is linked to cell cycle regulation. | ||||||
ACY-1215 | 1316214-52-4 | sc-507455 | 25 mg | $110.00 | ||
ACY-1215 stimulates Foxl3 by inhibiting histone deacetylases. Enhanced histone acetylation promotes Foxl3 transcriptional activity, contributing to its involvement in transcriptional regulation and cell differentiation processes. | ||||||